🇺🇸 Optimark® in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Optimark® on 8 December 1999

Marketing authorisation

FDA — authorised 8 December 1999

Application: NDA020937
Marketing authorisation holder: LIEBEL-FLARSHEIM
Local brand name: OPTIMARK
Indication: INJECTABLE — INJECTION
Status: approved

Read official source →

Frequently asked questions

Is Optimark® approved in United States?

Yes. FDA authorised it on 8 December 1999.

Who is the marketing authorisation holder for Optimark® in United States?

LIEBEL-FLARSHEIM holds the US marketing authorisation.